News & Events
Encapsulate Awarded $3.63M NASA InSPA Phase 1 Grant to Develop Microgravity-Based Metastasis-on-a-Chip Technology
Farmington, CT – Encapsulate, Inc., a precision medicine startup developing advanced biochip systems, has been awarded a $3.63 million Phase 1 grant through NASA’s In Space Production Applications (InSPA) program to develop a microgravity-enabled Metastasis-on-a-Chip...
Encapsulate Awarded $1.25M NSF SBIR Phase II Grant to Advance Automated Chemotherapy Selection Platform for Pancreatic and Colorectal Cancers
Farmington, CT – Encapsulate, Inc., a precision medicine startup developing automated biochip systems for personalized cancer treatment, has been awarded a $1.25 million Small Business Innovation Research (SBIR) Phase II grant from the National Science Foundation...
Encapsulate Seed Round is Closed with an Oversubscription
Encapsulate Closes $1.8M Oversubscribed Seed Round to Accelerate Personalized Cancer TherapyFarmington, CT – Encapsulate, a developer of personalized oncology solutions, has raised $1.8 million in seed funding, led by Blackwood Healthcare Breakthroughs, Ambit Health...
Encapsulate has won the Entrepreneurship World Cup 2nd Place in KSA
We are thrilled to announce that Encapsulate has secured 2nd place and a $75,000 cash prize at the 2024 Entrepreneurship World Cup Global Finals!Competing among the top 100 startups from 52 countries, Encapsulate was recognized...
Dr. Armin Rad Presented nCapsule’s Exciting Data from On-Orbit Studies
We are thrilled that we have presented at the ISSRDC conference in Boston with our groundbreaking study: "Encapsulate: Automated Biochips for Personalized Cancer Screening in Microgravity".For the first time, we'll be sharing the incredible data achieved from our...
US Senator Chris Murphy Highlights Farmington’s Encapsulate As “Innovator Of The Month”
HARTFORD–U.S. Senator Chris Murphy (D-Conn.) announced on Friday that Encapsulate, a Farmington-based medtech company founded by two UConn graduates, was named “Innovator of the Month” for their development of a transformative contribution to cancer treatment....
